欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1861/002
药品名称Alvesco
活性成分
    • Ciclesonide 160.0 µg
剂型Pressurised inhalation, solution
上市许可持有人Covis Pharma Europe B.V. The Netherlands
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Czechia (CZ)
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
    • Denmark (DK)
    • Netherlands (NL)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Alvesco 160
    • Latvia (LV)
      Alvesco 160 mikrogrami aerosols inhalācijām, zem spiediena, šķīdums
    • Hungary (HU)
      ALVESCO 160 mikrogramm túlnyomásos inhalációs oldat
    • Bulgaria (BG)
      Alvesco
    • Cyprus (CY)
    • Slovakia (SK)
      Alvesco 160 Inhalátor
    • Slovenia (SI)
许可日期2008/04/05
最近更新日期2025/09/09
药物ATC编码
    • R03BA08 ciclesonide
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase